Dr. Alexander Fanaroff, MD

• Cardiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Duke University Hospital

  Fellowship Hospital

• Duke University Hospital

  Residency Hospital, 2014

• Duke University Hospital

  Internship Hospital, 2012

• Duke University School Of Medicine

  Medical School, 2011

• Antithrombotic Agents for Secondary Prevention after Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis, 2017-03-14

• Socioeconomic and Geographic Characteristics of Hospitals Establishing Transcatheter Aortic Valve Replacement Programs, 2012-2018, 2021-10-21

• Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A pooled analysis of 9,259 Deaths in 9 trials, 2019-02-12

• Peripheral artery disease and transcatheter aortic valve replacement outcomes: A report from the STS/TVT Registry, 2017-09-19

• Intensive Care Unit Utilization Among Medicare Patients Hospitalized with Non-ST-Segment Elevation Myocardial Infarction, 2017-01-01

• Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair, 2020-10-24

• Days alive and out of hospital: Exploring a patient-centered, pragmatic outcome in a clinical trial of patients with acute coronary syndromes, 2018-12-18

• Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US Inequities Associated With Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes, 2021-12-17

• Association Between 90-Minute Door-to-Balloon Time, Selective Exclusion of Myocardial Infarction Cases, and Access Site Choice: Insights from the Cardiac Care Outcomes Assessment Program (COAP) in Washington State, 2020-09-04

• Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States, 2017-06-20

• Identifying racial, ethnic and socioeconomic inequities in the use of novel P2Y12 inhibitors after percutaneous coronary intervention, 2022-01-16

• Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events, 2020-04-09

• Association of health insurance payer type and outcomes after durable left ventricular assist device implantation - An analysis of the STS-INTERMACS registry, 2021-05-15

• Relationship between operator volume and long-term outcomes after percutaneous coronary intervention: A Report from the NCDR CathPCI Registry, 2019-01-22

• Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US Demographic Characteristics and SGLT2 Inhibitor Use Among Patients With Diabetes, 2021-04-15

• Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US, 2021-12-17